MENU
ENLV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Enlivex Therapeutics (ENLV) Ownership - Who owns Enlivex Therapeutics?
Industry: @Medical Specialties
Profile
Industry
Medical Specialties
Address
14 Einstein Street
Phone
+972 26208072
Employees
77
Web
https://www.enlivex.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
27.49M
P/E Ratio
N/A
Total Cash
24.51M
Projected Growth
N/A
Total Debt
765K
Revenue
N/A
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash/Share
1.11
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ENLV
Capitalization
27.5M
P/E Ratio
N/A
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash
24.5M
Total Cash/Share
1.11
Total Debt
765K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
26.6M
P/B Ratio
1.03
Cash Flow
N/A
Earnings
-0.98
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.5M
Current Ratio
9.71
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-15.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-49.35
Shares Held By Institutions
5.02M
Shares Outstanding - Current
22M
Total Liabilities
3.21M
Total Volume MTD
N/A
Value
1
Gain YTD
6.838
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
14 Einstein Street
Phone
+972 26208072
Employees
77
Web
https://www.enlivex.com